Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAPN2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | PPP1R13L | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
mRNA | PHF2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | VN1R1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | CBLN4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | MSANTD3-TMEFF1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
mRNA | IL18 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | OBFC1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
mRNA | PUM1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | SPAST | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |